Form 4: MariMed COO Timothy Shaw Receives RSU Grant

MariMed Inc. Chief Operating Officer Timothy Shaw was granted 170,625 restricted stock units in lieu of a cash bonus.

Summary

• Timothy Shaw, Chief Operating Officer of MariMed Inc., received a grant of 170,625 restricted stock units (RSUs) on April 15, 2026.
• The RSUs were issued as a substitute for a portion of the executive's annual cash bonus for the 2025 fiscal year.
• The units vest in four equal quarterly installments starting July 15, 2026, and concluding April 15, 2027.
• Following this transaction, the reporting person maintains direct ownership of 9,357,700 shares and indirect ownership of 2,000,000 shares via the Shaw Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event regarding executive compensation that does not signal a change in company strategy or financial health.

Positives

• The executive is accepting equity compensation in lieu of cash, which aligns management interests with long-term shareholder value.
• The grant structure includes a vesting schedule that encourages retention over the next year.

Negatives

• None identified; this is a standard compensation adjustment.

Risks

• The value of the equity compensation is subject to market volatility in MariMed Inc. common stock.
• Vesting is contingent upon continued employment through the specified dates.

Future Outlook

The RSUs will vest in four equal installments through April 2027, contingent on the executive's continued service.

Management Comments

• The RSUs were granted in lieu of cash payment of a portion of the Reporting Person's annual bonus for the fiscal year ended December 31, 2025.

Industry Context

StockSavvy.ai notes that it is common practice for cannabis sector executives to receive equity-based compensation to preserve corporate cash reserves, reflecting a broader trend of capital discipline in the industry.

Comparison to Industry Standards

• The use of equity-based compensation in lieu of cash is consistent with standard practices among mid-cap cannabis operators to manage liquidity.
• The vesting schedule of one year is relatively short compared to typical multi-year performance-based equity grants seen in larger public companies.

Related Party Transactions

• The reporting person holds 2,000,000 shares indirectly through the Shaw Family Trust, for which the reporting person's spouse is the trustee.

Stakeholder Impact

• Shareholders may view the conversion of cash bonuses to equity as a positive sign of management's confidence in the company's future performance.

Next Steps

• Vesting of the first installment of RSUs on July 15, 2026.

Key Dates

Keywords

MariMed, MRMD, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units